Literature DB >> 10660548

Engineered salt-insensitive alpha-defensins with end-to-end circularized structures.

Q Yu1, R I Lehrer, J P Tam.   

Abstract

We designed a retro-isomer and seven circularized "beta-tile" peptide analogs of a typical rabbit alpha-defensin, NP-1. The analogs retained defensin-like architecture after the characteristic end-to-end, Cys(3,31) (C I:C VI), alpha-defensin disulfide bond was replaced by a backbone peptide bond. The retro-isomer of NP-1 was as active as the parent compound, suggesting that overall topology and amphipathicity governed its antimicrobial activity. A beta-tile design with or without a single cross-bracing disulfide bond sufficed for antimicrobial activity, and some of the analogs retained activity against Escherichia coli and Salmonella typhimurium in NaCl concentrations that rendered NP-1 inactive. The new molecules had clustered positive charges resembling those in protegrins and tachyplesins, but were less cytotoxic. Such simplified alpha-defensin analogs minimize problems encountered during the oxidative folding of three-disulfide defensins. In addition, they are readily accessible to a novel thia zip cyclization procedure applicable to large unprotected peptide precursors of 31 amino acids in aqueous solutions. Collectively, these findings provide new and improved methodology to create salt-insensitive defensin-like peptides for application against bacterial diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10660548     DOI: 10.1074/jbc.275.6.3943

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

Review 1.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Biosynthesis and antimicrobial evaluation of backbone-cyclized α-defensins.

Authors:  Angie E Garcia; Kenneth P Tai; Shadakshara S Puttamadappa; Alexander Shekhtman; Andre J Ouellette; Julio A Camarero
Journal:  Biochemistry       Date:  2011-11-09       Impact factor: 3.162

Review 3.  Chemical synthesis of circular proteins.

Authors:  James P Tam; Clarence T T Wong
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

Review 4.  Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?

Authors:  Nicole K Brogden; Kim A Brogden
Journal:  Int J Antimicrob Agents       Date:  2011-07-05       Impact factor: 5.283

5.  Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.

Authors:  Berthony Deslouches; Kazi Islam; Jodi K Craigo; Shruti M Paranjape; Ronald C Montelaro; Timothy A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Antibacterial properties of the sperm-binding proteins and peptides of human epididymis 2 (HE2) family; salt sensitivity, structural dependence and their interaction with outer and cytoplasmic membranes of Escherichia coli.

Authors:  Suresh Yenugu; Katherine G Hamil; Charles E Birse; Steven M Ruben; Frank S French; Susan H Hall
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

7.  Antibacterial activity of human neutrophil defensin HNP-1 analogs without cysteines.

Authors:  Jobin Varkey; Ramakrishnan Nagaraj
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

8.  Activity of Genital Tract Secretions and Synthetic Antimicrobial Peptides against Group B Streptococcus.

Authors:  Nidhi Agarwal; Niall Buckley; Natasha Nakra; Philip Gialanella; Weirong Yuan; Jeny P Ghartey
Journal:  Am J Reprod Immunol       Date:  2015-09-23       Impact factor: 3.886

9.  Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3.

Authors:  Zhibin Wu; David M Hoover; De Yang; Cyril Boulègue; Fanny Santamaria; Joost J Oppenheim; Jacek Lubkowski; Wuyuan Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-02       Impact factor: 11.205

10.  Antimicrobial characterization of human beta-defensin 3 derivatives.

Authors:  David M Hoover; Zhibin Wu; Kenneth Tucker; Wuyuan Lu; Jacek Lubkowski
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.